ATE557276T1 - Spezifisches verfahren zum krebsnachweis - Google Patents

Spezifisches verfahren zum krebsnachweis

Info

Publication number
ATE557276T1
ATE557276T1 AT04791917T AT04791917T ATE557276T1 AT E557276 T1 ATE557276 T1 AT E557276T1 AT 04791917 T AT04791917 T AT 04791917T AT 04791917 T AT04791917 T AT 04791917T AT E557276 T1 ATE557276 T1 AT E557276T1
Authority
AT
Austria
Prior art keywords
specific method
detecting cancer
specific
qualitative
diagnosis
Prior art date
Application number
AT04791917T
Other languages
English (en)
Inventor
Patrizia Pontisso
Luca Beneduce
Giorgio Fassina
Maria Marino
Original Assignee
Xeptagen S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xeptagen S P A filed Critical Xeptagen S P A
Application granted granted Critical
Publication of ATE557276T1 publication Critical patent/ATE557276T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AT04791917T 2003-10-30 2004-10-26 Spezifisches verfahren zum krebsnachweis ATE557276T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000264A ITPD20030264A1 (it) 2003-10-30 2003-10-30 Metodo di diagnosi altamente specifico per neoplasie
PCT/IT2004/000583 WO2005043165A2 (en) 2003-10-30 2004-10-26 Specific method for cancer detection

Publications (1)

Publication Number Publication Date
ATE557276T1 true ATE557276T1 (de) 2012-05-15

Family

ID=34531934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791917T ATE557276T1 (de) 2003-10-30 2004-10-26 Spezifisches verfahren zum krebsnachweis

Country Status (4)

Country Link
EP (3) EP1678503B1 (de)
AT (1) ATE557276T1 (de)
IT (1) ITPD20030264A1 (de)
WO (1) WO2005043165A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
CA2629793A1 (en) * 2005-11-16 2007-05-24 Marsha A. Moses Method to assess breast cancer risk
CA2646329C (en) 2006-03-20 2018-07-03 The Regents Of The University Of California Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
EP2197491A4 (de) 2007-09-04 2011-01-12 Univ California Hochaffine anti-prostata-stammzell-antigen-(psca-) antikörper gegen krebs und zum nachweis von krebs
JP5906090B2 (ja) 2009-02-17 2016-04-20 コーネル・リサーチ・ファンデーション・インコーポレイテッドＣｏｒｎｅｌｌ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ 癌の診断のための方法およびキットならびに治療価の推定
EP2460012B1 (de) * 2009-07-29 2016-04-20 Randox Laboratories Ltd. Verfahren für den nachweis von blasenkrebs bzw. des risikos für blasenkrebs
CA2782333C (en) 2009-12-02 2019-06-04 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
WO2011085165A2 (en) * 2010-01-08 2011-07-14 The Brigham And Women's Hospital, Inc. Ca-125 immune complexes as biomarkers of ovarian cancer
BR112013013869A2 (pt) 2010-12-06 2016-12-06 Thd Spa método para diagnóstico de um carcinoma e usos do mesmo
NZ703411A (en) 2012-06-27 2017-09-29 Berg Llc Use of markers in the diagnosis and treatment of prostate cancer
GB201218570D0 (en) 2012-10-16 2012-11-28 Randox Lab Ltd Method
WO2015117953A1 (en) * 2014-02-04 2015-08-13 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (vegf)
EP3102943B1 (de) 2014-02-04 2018-10-31 CellTrend GmbH Krebsdiagnose mittels nachweis von autoantikörpern gegen den vaskulären endothelialen wachstumsfaktorrezeptor (vegfr)
EP3102947B1 (de) * 2014-02-04 2018-11-14 CellTrend GmbH Diagnose von krebs durch nachweis von autoantikörpern gegen par1
WO2015117952A1 (en) * 2014-02-04 2015-08-13 Celltrend Gmbh Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (egf)
EP3102944B1 (de) 2014-02-04 2018-10-10 CellTrend GmbH Krebsdiagnose mittels nachweis von autoantikörpern gegen den egf-receptor
CN104062437A (zh) * 2014-06-12 2014-09-24 上海交通大学医学院附属瑞金医院 Erbb2蛋白在制备检测嗜铬细胞瘤转移试剂中的应用
SG10202012249YA (en) 2014-12-08 2021-01-28 Berg Llc Use of markers including filamin a in the diagnosis and treatment of prostate cancer
CN104991065B (zh) * 2015-07-07 2017-01-11 复旦大学附属金山医院 一种用于诊断乳腺癌的三联标志物及其应用
EP4137158A1 (de) 2015-08-07 2023-02-22 Imaginab, Inc. Gegen moleküle gerichtete antigenbindende konstrukte
WO2017201225A1 (en) * 2016-05-19 2017-11-23 Poc Medical Systems, Inc. Cancer screening via detection and quantification of multiple biomarkers
CN106468711A (zh) * 2016-09-07 2017-03-01 北京热景生物技术股份有限公司 Dcp快速分离检测试剂盒
GB201619954D0 (en) * 2016-11-25 2017-01-11 Oncimmune Ltd Antibody assay
US11266745B2 (en) 2017-02-08 2022-03-08 Imaginab, Inc. Extension sequences for diabodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
US4711839A (en) * 1985-01-11 1987-12-08 Imre Corporation Immune complex assay
EP0529007A1 (de) * 1990-04-18 1993-03-03 The Regents Of The University Of California 35 kd eumor-assoziiertes proteinantigen und immunkomplex
WO1994008597A1 (en) * 1992-10-14 1994-04-28 The Scripps Research Institute Methods for the detection of antigen-specific immune complexes
AU2001247722A1 (en) * 2000-03-27 2001-10-08 Diagen Corporation Antigen-specific enzyme-linked immunosorbent assay
IT1317355B1 (it) * 2000-07-28 2003-06-16 Xeptagen S R L Anticorpi policlonali.

Also Published As

Publication number Publication date
EP2339345A1 (de) 2011-06-29
WO2005043165A2 (en) 2005-05-12
ITPD20030264A1 (it) 2005-04-30
EP1678503B1 (de) 2012-05-09
EP2367005A1 (de) 2011-09-21
EP1678503A2 (de) 2006-07-12
WO2005043165A3 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
ATE557276T1 (de) Spezifisches verfahren zum krebsnachweis
DE602007009645D1 (de) Reagenzien und verfahren für krebsprognose und pathologische einstufung
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
ATE551367T1 (de) Epha2-bindende antikörper und verfahren zu ihrer verwendung
ATE438737T1 (de) Verfahren für den nachweis von erkrankungen
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
CY1113260T1 (el) ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΚΑΡΚΙΝΟΥ ME TO ANTI-ErbB2 ΑΝΑΣΥΝΔΥΑΣΜΕΝΟ ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟ ΜΟΝΟΚΛΩΝΙΚΟ ΑΝΤΙΣΩΜΑ 2C4 (rhuMab 2C4)
DK1200832T3 (da) Annexiner og autoantistoffer anvendt som markörer for lungecancer og ösofageal cancer
CY1110923T1 (el) Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων
DE602004022943D1 (de) Verfahren zum nachweis von analyten auf grundlage von evaneszenzbelichtung und auf streuung beruhender nachweis von nanopartikelsondenkomplexen
DE602006016567D1 (de) Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs
DE602005008787D1 (de) Nahrungsmittelanalysator für autonom angetriebene Futterstationen, sowie Verfahren dafür
DE60226271D1 (de) Verfahren zum nachweis von prostatakrebs
DE60104392D1 (de) Verfahren zum nachweis der effektivität einer krebstherapie
DE69535802D1 (de) Genetische veränderungen, die mit lungencarzinomen korrelieren
CY1122156T1 (el) Αντισωματα κατα του σχετιζομενου με τον νεφρο αντιγονου 1 και αντιγονοδεσμευτικα θραυσματα αυτων
DE602004028513D1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
GB2437545B (en) Dextrin-containing reagents for detecting and quantifying proteins
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
EP1896849A4 (de) Antikörper gegen histonmodifikationen für die klinische krebsdiagnose und -prognose
CY1113013T1 (el) Βελτιωμενες μεθοδοι ανοσολογικων δοκιμασιων
ATE503186T1 (de) Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen proben
DE602004016906D1 (de) Reagenz zum Nachweis von anti-Phospholipid Antikörper